Cannabis fintech firm SHF Holdings' Q3 revenue rises on loan program income growth

By Reuters News


Overview

  • US cannabis fintech platform's Q3 revenue rose 6.5% yr/yr, driven by loan program income growth

  • Operating loss for Q3 narrowed 17.7% yr/yr due to higher revenue and lower compensation expenses

  • Company entered nonbinding term sheet for proposed business combination with Opifex Media


Outlook

  • Company does not intend to draw on its equity line of credit while the Opifex term sheet remains in effect


Result Drivers

  • LOAN PROGRAM INCOME - Revenue growth was primarily driven by a 70.2% increase in loan program income, attributed to improved revenue-sharing economics under an amended agreement with Partner Colorado Credit Union

  • CLIENT DEPOSIT GROWTH - Average client deposit balances rose 3.8% yr/yr to $112 mln, with quarter-end trailing 14-day average deposits reaching $119.3 mln, reflecting a shift toward larger, higher-deposit-balance client relationships

  • LOWER COMPENSATION EXPENSES - Operating loss narrowed due in part to a 10.6% decrease in compensation and employee benefits expenses


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

$1.95 mln


Reuters Recommended Reads

  • Nov 6 - Binance $6.3 billion heist to prompt closer scrutiny by insurers

  • Nov 6 - Ares Commercial Real Estate Q3 net income beats estimates

  • Nov 6 - Humana Q3 adjusted loss narrows on Medicaid businesses, revenue slightly beats estimates


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.